Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Hall purchased 2,270 shares of the stock in a transaction on Tuesday, December 23rd. The stock was acquired at an average cost of A$220.31 per share, with a total value of A$500,103.70.
Anthony Hall also recently made the following trade(s):
- On Monday, December 22nd, Anthony Hall purchased 2,250 shares of Pro Medicus stock. The shares were purchased at an average price of A$221.90 per share, for a total transaction of A$499,275.00.
Pro Medicus Stock Performance
The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10. The stock has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56.
Pro Medicus Company Profile
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
See Also
- Five stocks we like better than Pro Medicus
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Elon Warns “America Is Broke”. Trump’s Plan Inside.
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
